AB-1002 is an investigational one-time gene therapy administered directly to the heart to promote production of a modified ...
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...
A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”), a biopharmaceutical ...
A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...
Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety ...
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...
LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS ® 2.0, an application that ...
Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. | Bristol Myers ...
Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
The University of Rochester Medical Center is celebrating the grand reopening of its Clinical Research Center.
The University of Rochester reopened its newly redesigned Clinical Research Center more than two years after a devastating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results